Pharmaceutical Market Europe • October 2024 • 35
HEALTHCARE COMMS
Executive Insight opens New York office to better serve US biopharma clients
Executive Insight has announced that its New York office will open at the beginning of January 2025, bringing the healthcare consultancy closer to its US-based biopharmaceutical clients.
The new office, which is situated between Times Square and the Empire State Building, adds to the company’s pre-existing offices in the UK and Switzerland.
The announcement follows the recent official incorporation of Executive Insight USA, which will now be able to serve its US clients more directly and in closer proximity.
The US team’s offering includes services along the entire drug life cycle, including market access, medical affairs, patient affairs, as well as government affairs.
One of the focus topics of the team of consultants in the US is healthcare improvement, for better care and enhanced patient outcomes, the firm outlined.
Lisa Clark, principal at Executive Insight Healthcare Consultants and US expansion lead, said: “New York is the perfect addition to our Zurich and London offices and our locations now match our global client base.”
Andrea Sobrio, founder and managing partner at Executive Insight, added: “This step is a crucial milestone in the continuing strategic development of our company.”
Executive Insight was founded in 2000 in Switzerland and expanded to London 17 years later.
In July this year, the firm opened its own “dedicated and expanded” London office “designed to meet the evolving needs of [its] growing team”.
Commenting on the new Great Tower Street location, which remains close to the company’s former office in the heart of the city, Sobrio said: “I feel that in this cosy, beautiful home for our UK team, we will be able to feel comfortable for the years to come, celebrate many successes as a team and together with our clients, and embark on an exciting journey lying ahead of us.”
Wilmington Healthcare
relaunches as HSJ Information
Wilmington Healthcare has announced that it has relaunched as HSJ Information, following Inspirit Capital’s recent acquisition of the business.
The new company comprises multiple divisions, including HSJ, the journal for healthcare leaders; and HSJ Advisory, a consultancy specialising in NHS-industry partnership, market access and optimising go-to-market strategy and operations.
HSJ Marketing Solutions, which offers granularity, compliance and reach for NHS marketing engagement, and HSJ Market Intelligence, a UK NHS data analysis agency, are also included in the group, as are HSJ Events and HSJ Jobs.
HSJ Information works with life sciences companies – pharma, medtech, diagnostics and digital – to “optimise their planning, execute launches, advance their customer engagement and ultimately build partnerships with the NHS”, according to managing director, Steve Harvey.
The company said it does this leveraging its “unique data, knowledge, connections and insights”, alongside its team of consultants, data scientists and journalists.
Head of advisory, Julian Snape, outlined that HSJ Advisory “exists to build bridges between the NHS and industry”.
“We can look at what your offering is, who you’re trying to reach, where you’re trying to target and why the NHS should work with you – and offer advice, insight and strategy going forward, based on our team’s experience in the NHS and industry,” he said.
Speaking specifically on HSJ Market Intelligence, director of innovation and strategy, Jonathan Carney, said: “HSJ Market Intelligence solutions continuously strives to develop novel analytical tools to help drive awareness and improve the health and social care sector,… distilling large data sets into meaningful insights for both you and your NHS partners.”
The rebrand comes shortly after Inspirit Capital acquired Wilmington Healthcare from Wilmington plc earlier this year.
Will Stamp, founding partner at Inspirit Capital, said at the time of the June announcement: “It is a truly differentiated business given its integrated offering and is well-positioned to capitalise on the ongoing growth in demand for data and information services across the UK healthcare space.”
HSJ has been under the Wilmington umbrella since 2017, when Wilmington plc reached an agreement to acquire the brand from Ascential, its owner since 1997.
Steve Harvey
Julian Snape
Jonathan Carney
Pharmaceutical Market Europe (PME)
Pharmaceutical industry news, articles, jobs, reports, advice and services